{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:28:35Z","timestamp":1780378115525,"version":"3.54.1"},"reference-count":120,"publisher":"Oxford University Press (OUP)","issue":"935","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Giant cell arteritis (GCA), temporal arteritis or Horton\u2019s arteritis, is a systemic vasculitis which involves large and medium sized vessels, especially the extracranial branches of the carotid arteries, in persons usually older than 50 years. Permanent visual loss, ischaemic strokes, and thoracic and abdominal aortic aneurysms are feared complications of GCA. The treatment consists of high dose steroids. Mortality, with a correct treatment, in patients with GCA seems to be similar that of controls.<\/jats:p>","DOI":"10.1136\/pmj.79.935.511","type":"journal-article","created":{"date-parts":[[2003,9,17]],"date-time":"2003-09-17T20:38:08Z","timestamp":1063831088000},"page":"511-515","source":"Crossref","is-referenced-by-count":39,"title":["Giant cell arteritis"],"prefix":"10.1093","volume":"79","author":[{"given":"J M","family":"Calvo-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,9,17]]},"reference":[{"key":"2023042410461377800_R1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0889-857X(05)70153-8","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"26","author":"Evans","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"2023042410461377800_R2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"2023042410461377800_R3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","article-title":"Systemic vasculitis in adults in northwestern Spain, 1988\u20131997: clinical and epidemiologic aspects","volume":"78","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"Medicine"},{"key":"2023042410461377800_R4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","article-title":"Temporal arteritis. A 25 year epidemiological, clinical and pathologic study","volume":"88","author":"Huston","year":"1978","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R5","first-page":"1739","article-title":"The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: a prospective study 1987\u20131994","volume":"24","author":"Gran","year":"1997","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.1780240706","article-title":"The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: incidences of different clinical presentations and eye complications","volume":"24","author":"Bengtsson","year":"1981","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780370705","article-title":"Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis","volume":"37","author":"Baldursson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0248-8663(82)80003-9","article-title":"[Epidemiologic approach to Horton\u2019s disease in the department of Loire-Atlantique. 110 cases in 10 years (1970\u20131979)]","volume":"3","author":"Barrier","year":"1983","journal-title":"Rev Med Interne"},{"key":"2023042410461377800_R10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950\u20131985","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/rheumatology\/33.10.938","article-title":"Giant cell arteritis in Jerusalem: a 12-year epidemiological study","volume":"33","author":"Sonnenblick","year":"1994","journal-title":"Br J Rheumatol"},{"key":"2023042410461377800_R12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell artertis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.60.4.367","article-title":"Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period","volume":"60","author":"Gonzalez-Gay","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2023042410461377800_R14","first-page":"734","article-title":"[Giant cell arteritis. A study of 191 patients]","volume":"105","author":"Armona","year":"1995","journal-title":"Med Clin (Barc)"},{"key":"2023042410461377800_R15","first-page":"67","article-title":"[Giant-cell arteritis: a descriptive study in southwestern Spain]","volume":"17","author":"Calvo Romero","year":"2000","journal-title":"Ann Med Interna (Madrid)"},{"key":"2023042410461377800_R16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0248-8663(01)00400-3","article-title":"[Inaugural symptoms of Horton\u2019s disease in a series of 260 patients]","volume":"22","author":"Becourt-Verlomme","year":"2001","journal-title":"Rev Med Interne"},{"key":"2023042410461377800_R17","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R18","first-page":"1551","article-title":"Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families","volume":"29","author":"Fietta","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R19","first-page":"112","article-title":"Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma penumoniae infection","volume":"23","author":"Elling","year":"1996","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8","article-title":"Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells","volume":"43","author":"Wagner","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R21","first-page":"2718","article-title":"Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen","volume":"27","author":"Rimenti","year":"2000","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R22","first-page":"361","article-title":"Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l\u2019Arterite a Cellules Geantes","volume":"26","author":"Duhaut","year":"1999","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","article-title":"The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.STR.17.2.325","article-title":"Temporal arteritis-like presentation of carotid atherosclerosis","volume":"17","author":"Venna","year":"1986","journal-title":"Stroke"},{"key":"2023042410461377800_R26","first-page":"360","article-title":"Giant cell arteritis involving the facial artery","volume":"22","author":"Achkar","year":"1995","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00325481.1983.11697764","article-title":"Jaw claudication: its value as a diagnostic clue","volume":"73","author":"Goodman","year":"1983","journal-title":"Postgrad Med"},{"key":"2023042410461377800_R28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-198605000-00005","article-title":"Jaw claudication in primary systemic amyloidosis","volume":"65","author":"Gertz","year":"1986","journal-title":"Medicine"},{"key":"2023042410461377800_R29","first-page":"707","article-title":"A case of Wegener\u2019s granulomatosis presenting with jaw claudication","volume":"11","author":"Vermuelen","year":"1984","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.61.9.832","article-title":"Reduction of jaw opening (trismus) in giant cell arteritis","volume":"61","author":"Nir-Paz","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2023042410461377800_R31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0030-4220(92)90348-T","article-title":"Necrosis of the tongue in a patient with intestinal infarction","volume":"74","author":"Patterson","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2023042410461377800_R32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0002-9343(76)90335-1","article-title":"Bilateral scalp necrosis in temporal arteritis: a rare complication of Horton\u2019s disease","volume":"61","author":"Sonderstrom","year":"1976","journal-title":"Am J Med"},{"key":"2023042410461377800_R33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005792-200301000-00002","article-title":"Audiovestibular manifestations in giant cell arteritis: a prospective study","volume":"82","author":"Amor-Dorado","year":"2003","journal-title":"Medicine"},{"key":"2023042410461377800_R34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00055735-199812000-00013","article-title":"Ocular manifestations of giant cell arteritis","volume":"9","author":"Tovilla-Canales","year":"1998","journal-title":"Curr Opin Ophthalmol"},{"key":"2023042410461377800_R35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"2023042410461377800_R36","first-page":"240","article-title":"Ocular muscle paresis and cranial arteritis\u2014an unusual case","volume":"15","author":"Goldberg","year":"1983","journal-title":"Ann Ophthalmol"},{"key":"2023042410461377800_R37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine"},{"key":"2023042410461377800_R38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"2023042410461377800_R39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.303.6806.825","article-title":"Thrombocytois and ischaemic complications in giant cell arteritis","volume":"303","author":"De Keyser","year":"1991","journal-title":"BMJ"},{"key":"2023042410461377800_R42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(90)90100-R","article-title":"Neurologic manifestations of giant cell arteritis","volume":"89","author":"Reich","year":"1990","journal-title":"Am J Med"},{"key":"2023042410461377800_R44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/anr.1780321017","article-title":"Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly","volume":"32","author":"Pascuzzi","year":"1989","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.40.5.753","article-title":"Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia","volume":"40","author":"Caselli","year":"1990","journal-title":"Neurology"},{"key":"2023042410461377800_R46","first-page":"1556","article-title":"Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma","volume":"29","author":"Fruchter","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.38.5.685","article-title":"Peripheral neuropathic syndromes in giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"2023042410461377800_R48","first-page":"2653","article-title":"Brachial plexopathy as a presenting symptom of giant cell arteritis","volume":"29","author":"Chowdhry","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/BF01411272","article-title":"Giant cell arteritis with subarachnoid haemorrhage due to the rupture of inflammatory aneurysm of the posterior inferior cerebellar artery","volume":"138","author":"Takahashi","year":"1996","journal-title":"Acta Neurochir"},{"key":"2023042410461377800_R50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.298.6666.75","article-title":"Predisposing factors for cerebral infarction: the Oxfordshire community stroke project","volume":"298","author":"Sandercock","year":"1989","journal-title":"BMJ"},{"key":"2023042410461377800_R51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200301000-00001","article-title":"Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature","volume":"82","author":"Ruegg","year":"2003","journal-title":"Medicine"},{"key":"2023042410461377800_R52","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.1780371020","article-title":"Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases","volume":"37","author":"Evans","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneuysm and dissection in giant cell (temporal) arteritis. A population based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0049-0172(95)80010-7","article-title":"Aortic and extracranial large vessel giant cell arteritis. A review of 72 cases with histopathological documentation","volume":"24","author":"Lie","year":"1995","journal-title":"Sem Arthritis Rheum"},{"key":"2023042410461377800_R55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s100670050056","article-title":"Superior and inferior limb ischemia in giant cell arteritis: angiography follow-up","volume":"18","author":"Garcia-Vazquez","year":"1999","journal-title":"Clin Rheumatol"},{"key":"2023042410461377800_R56","first-page":"1407","article-title":"Lower limb giant cell arteritis and temporal arteritis: follow up of 8 cases","volume":"28","author":"Le Hello","year":"2001","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0954-6820.1980.tb01190.x","article-title":"Coronary ischaemia and occlusion in giant cell (temporal) arteritis","volume":"208","author":"Paulley","year":"1980","journal-title":"Acta Med Scand"},{"key":"2023042410461377800_R59","first-page":"315","article-title":"[Pulmonary artery thrombosis in giant cell arteritis. A new case and review of literature]","volume":"148","author":"Landrin","year":"1997","journal-title":"Ann Med Interne (Paris)"},{"key":"2023042410461377800_R60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.62.2.189","article-title":"Intra-alveolar haemorrhage in temporal arteritis","volume":"62","author":"Huong Dle","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2023042410461377800_R61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/pgmj.74.869.170","article-title":"Giant cell arteritis presenting as renal vasculitis","volume":"74","author":"Govil","year":"1998","journal-title":"Postgrad Med J"},{"key":"2023042410461377800_R62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s100670200100","article-title":"Microscopic haematuria in giant cell arteritis","volume":"21","author":"Vanderschueren","year":"2002","journal-title":"Clin Rheumatol"},{"key":"2023042410461377800_R63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/ajkd.2002.34931","article-title":"Isolated renal giant cell arteritis","volume":"40","author":"Medvedev","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2023042410461377800_R64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/03009740151095448","article-title":"Giant cell arteritis and secondary amyloidosis: the natural history","volume":"30","author":"Altiparmak","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"2023042410461377800_R65","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R66","first-page":"514","article-title":"Giant cell arterits in polymyalgia rheumatica","volume":"102","author":"Hunder","year":"1997","journal-title":"Am J Med"},{"key":"2023042410461377800_R67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(97)00117-4","article-title":"Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica","volume":"102","author":"Rodriguez-Valverde","year":"1997","journal-title":"Am J Med"},{"key":"2023042410461377800_R68","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica","volume":"25","author":"Gonz\u00e1lez-Gay","year":"1998","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R69","first-page":"73","article-title":"Giant cell arteritis with an erythrocyte sediemtation rate lower than 50","volume":"19","author":"Martinez-Taboada","year":"2000","journal-title":"Clin Rheumatol"},{"key":"2023042410461377800_R70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R71","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"key":"2023042410461377800_R72","first-page":"155","article-title":"A reduced CD8+ lymphocyte subset distinguishes patients with polymyalgia rheumatica and temporal arteritis from patients with other diseases","volume":"16","author":"Elling","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2023042410461377800_R73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/sarh.2001.9734","article-title":"Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review","volume":"30","author":"Martinez-Taboada","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"2023042410461377800_R74","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","article-title":"Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity","volume":"43","author":"Weyand","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R75","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P","article-title":"Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l\u2019Arterite a Cellules Geantes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R76","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/39.10.1089","article-title":"Anticardiolipin antibody levels predict flares and relapses in patients with giant cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases","volume":"39","author":"Liozon","year":"2000","journal-title":"Rheumatology"},{"key":"2023042410461377800_R77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0025-6196(12)65593-1","volume":"59","author":"Hall","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"2023042410461377800_R78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.315.7107.549","article-title":"Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy (letter)","volume":"315","author":"Sudlow","year":"1997","journal-title":"BMJ"},{"key":"2023042410461377800_R79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jcp.53.2.131","article-title":"Temporal artery biopsy: is there any value in examining biopsies at multiple levels?","volume":"53","author":"Chakrabarty","year":"2000","journal-title":"J Clin Pathol"},{"key":"2023042410461377800_R80","first-page":"93","article-title":"The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis","volume":"22","author":"Gabriel","year":"1995","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"2023042410461377800_R82","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0161-6420(02)01758-X","article-title":"The role of unilateral temporal artery biopsy","volume":"110","author":"Hall","year":"2003","journal-title":"Ophthalmology"},{"key":"2023042410461377800_R83","first-page":"3","article-title":"[Diagnostic value of clinical signs in giant cell arteritis: analysis of 415 temporal artery biopsy findings]","volume":"153","author":"Strady","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"2023042410461377800_R84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1067\/mva.2002.129648","article-title":"The utility of color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"36","author":"LeSar","year":"2002","journal-title":"J Vasc Surg"},{"key":"2023042410461377800_R85","first-page":"1224","article-title":"The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis","volume":"29","author":"Nesher","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R86","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-137-4-200208200-00006","article-title":"Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?","volume":"137","author":"Salvarani","year":"2002","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R87","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archinte.161.7.1003","article-title":"Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis","volume":"161","author":"Turlakow","year":"2001","journal-title":"Arch Intern Med"},{"key":"2023042410461377800_R88","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/rheumatology\/38.8.709","article-title":"Temporal 67gallium uptake is increased in temporal arteritis","volume":"38","author":"Genereau","year":"1999","journal-title":"Rheumatology"},{"key":"2023042410461377800_R89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0950-3579(05)80067-6","article-title":"Treatment of polymyalgia rheumatica\/giant cell arteritis","volume":"5","author":"Kyle","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"key":"2023042410461377800_R90","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","article-title":"The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment","volume":"52","author":"Kyle","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2023042410461377800_R91","first-page":"303","article-title":"Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study","volume":"15","author":"Nesher","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"2023042410461377800_R92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis","volume":"47","author":"Hernandez-Rodriguez","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R93","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/jama.1980.03310150049032","article-title":"Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness","volume":"244","author":"Blumberg","year":"1980","journal-title":"JAMA"},{"key":"2023042410461377800_R94","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0248-8663(01)00399-X","article-title":"[Horton\u2019s disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose]","volume":"22","author":"Chevalet","year":"2001","journal-title":"Rev Med Interne"},{"key":"2023042410461377800_R95","first-page":"1484","article-title":"A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients","volume":"27","author":"Chevalet","year":"2000","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R96","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archneur.57.4.581","article-title":"Deterioration of giant cell arteritis with corticosteroid therapy","volume":"57","author":"Staunton","year":"2000","journal-title":"Arch Neurol"},{"key":"2023042410461377800_R97","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.85.9.1061","article-title":"Steroid management in giant cell arteritis","volume":"85","author":"Chan","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"2023042410461377800_R98","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"2023042410461377800_R99","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0161-6420(02)01775-X","article-title":"Recovery of visual function in patients with biopsy-proven giant cell arteritis","volume":"110","author":"Foroozan","year":"2003","journal-title":"Ophthalmology"},{"key":"2023042410461377800_R100","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0161-6420(97)30222-X","article-title":"Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone","volume":"104","author":"Cornblath","year":"1997","journal-title":"Ophthalmology"},{"key":"2023042410461377800_R101","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-120-12-199406150-00003","article-title":"How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?","volume":"120","author":"Achkar","year":"1994","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R102","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bjo.86.5.530","article-title":"Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis","volume":"86","author":"Ray-Chaudhuri","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"2023042410461377800_R103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R104","first-page":"2474","article-title":"Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss","volume":"28","author":"Cacoub","year":"2001","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02249029","article-title":"Steroid sparing medications in temporal arteritis\u2014report of three cases and review of 174 reported cases","volume":"13","author":"Nesher","year":"1994","journal-title":"Clin Rheumatol"},{"key":"2023042410461377800_R106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"2023042410461377800_R107","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2023042410461377800_R108","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"International Network for the Study of Systemic Vasculitides. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.10071","article-title":"Therapeutic effects of acetylsalicylic acid in giant cell arteritis","volume":"46","author":"Weyand","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R110","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y","article-title":"Treatment of longstanding active giant cell arteritis with infliximab: report of four cases","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023042410461377800_R111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.62.4.373","article-title":"Successful treatment of resistant giant cell arteritis with etanercept","volume":"62","author":"Tan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2023042410461377800_R112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"2023042410461377800_R113","first-page":"2171","article-title":"Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality","volume":"24","author":"Gonz\u00e1lez-Gay","year":"1997","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R114","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","article-title":"Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls","volume":"40","author":"Gran","year":"2001","journal-title":"Rheumatology"},{"key":"2023042410461377800_R115","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R116","first-page":"171","article-title":"Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis","volume":"19","author":"Hachulla","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2023042410461377800_R117","first-page":"1283","article-title":"Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients","volume":"21","author":"Nesher","year":"1994","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R118","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/pgmj.71.838.500","article-title":"Polymyalgia rheumatica, temporal arteritis and malignancy","volume":"71","author":"Speed","year":"1995","journal-title":"Postgrad Med J"},{"key":"2023042410461377800_R119","first-page":"1335","article-title":"Cancer in association with polymyalgia rheumatica and temporal arteritis","volume":"20","author":"Haga H-J, Eide","year":"1993","journal-title":"J Rheumatol"},{"key":"2023042410461377800_R120","first-page":"2143","article-title":"No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls","volume":"29","author":"Myklebust","year":"2002","journal-title":"J Rheumatol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/79\/935\/511\/50039534\/postgradmedj-79-511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/79\/935\/511\/50039534\/postgradmedj-79-511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T11:13:09Z","timestamp":1682334789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/79\/935\/511\/7045798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":120,"journal-issue":{"issue":"935","published-online":{"date-parts":[[2003,9,17]]},"published-print":{"date-parts":[[2003,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.79.935.511","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,9]]},"published":{"date-parts":[[2003,9,1]]}}}